Search research articles
Contact Us
Filters
Showing results (351-360 of 382) with videos related to
Page
of 39
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
February 23, 2016
Identification of potent and selective MTH1 inhibitors
Alessia Petrocchi, Elisabetta Leo, Naphtali J Reyna, et al.
BMC Medical Genomics
|
June 12, 2021
A blood RNA transcriptome signature for COVID-19
Philip Kam Weng Kwan, Gail B Cross, Claire M Naftalin, et al.
The Journal of Infectious Diseases
|
March 25, 2024
Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial
Nicholas I Paton, Meera Gurumurthy, Qingshu Lu, et al.
Journal of Medical Virology
|
February 16, 2022
Discrepant serological findings in SARS-CoV-2 PCR-negative hospitalized patients with fever and acute respiratory symptoms during the pandemic
Gail B Cross, Claire M Naftalin, Jinghao N Ngiam, et al.
Journal of Medicinal Chemistry
|
October 14, 2015
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors
Jing Zhang, Qingyi Yang, Jason B Cross, et al.
Journal of Medicinal Chemistry
|
July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Kang Le, Michael J Soth, Jason B Cross, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design
Jason B Cross, Jing Zhang, Qingyi Yang, et al.
RSC Medicinal Chemistry
|
September 19, 2025
Allosteric targeting of RIPK1: discovery of novel inhibitors <i>via</i> parallel virtual screening and structure-guided optimization
R S K Vijayan, Matthew M Hamilton, Dana E Pfaffinger, et al.
Infectious Diseases and Therapy
|
January 12, 2021
Clinical Diagnostic Study of a Novel Injection Molded Swab for SARS-Cov-2 Testing
Joshua K Tay, Gail B Cross, Louisa Sun, et al.
Nature Communications
|
September 24, 2025
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity
Xiuning Le, Jacqulyne P Robichaux, Monique Nilsson, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 382) with videos related to
Sort By:
Page
of 39
Bioorganic & Medicinal Chemistry Letters
|
February 23, 2016
Identification of potent and selective MTH1 inhibitors
Alessia Petrocchi, Elisabetta Leo, Naphtali J Reyna, et al.
BMC Medical Genomics
|
June 12, 2021
A blood RNA transcriptome signature for COVID-19
Philip Kam Weng Kwan, Gail B Cross, Claire M Naftalin, et al.
The Journal of Infectious Diseases
|
March 25, 2024
Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial
Nicholas I Paton, Meera Gurumurthy, Qingshu Lu, et al.
Journal of Medical Virology
|
February 16, 2022
Discrepant serological findings in SARS-CoV-2 PCR-negative hospitalized patients with fever and acute respiratory symptoms during the pandemic
Gail B Cross, Claire M Naftalin, Jinghao N Ngiam, et al.
Journal of Medicinal Chemistry
|
October 14, 2015
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors
Jing Zhang, Qingyi Yang, Jason B Cross, et al.
Journal of Medicinal Chemistry
|
July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Kang Le, Michael J Soth, Jason B Cross, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design
Jason B Cross, Jing Zhang, Qingyi Yang, et al.
RSC Medicinal Chemistry
|
September 19, 2025
Allosteric targeting of RIPK1: discovery of novel inhibitors <i>via</i> parallel virtual screening and structure-guided optimization
R S K Vijayan, Matthew M Hamilton, Dana E Pfaffinger, et al.
Infectious Diseases and Therapy
|
January 12, 2021
Clinical Diagnostic Study of a Novel Injection Molded Swab for SARS-Cov-2 Testing
Joshua K Tay, Gail B Cross, Louisa Sun, et al.
Nature Communications
|
September 24, 2025
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity
Xiuning Le, Jacqulyne P Robichaux, Monique Nilsson, et al.
Page
of 39